Price target
12.520.000.00%
The 3 analysts offering 1 year price forecasts for EPRX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to EPRX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
EPRX EPS for the last quarter is −0.17 CAD despite the estimation of −0.18 CAD. In the next quarter EPS is expected to reach −0.20 CAD. Track more of EUPRAXIA PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter EUPRAXIA PHARMACEUTICALS INC revenue is expected to reach 0.00 CAD. Check out EUPRAXIA PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, EPRX price target is 12.52 CAD with a max estimate of 16.73 CAD and a min estimate of 8.25 CAD. Check if this forecast comes true in a year, meanwhile watch EUPRAXIA PHARMACEUTICALS INC stock price chart and keep track of the current situation with EPRX news and stock market news.